Wealth Management Partners LLC Purchases 11,979 Shares of ARK Genomic Revolution ETF $ARKG

Wealth Management Partners LLC raised its position in ARK Genomic Revolution ETF (BATS:ARKG) by 78.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,319 shares of the company’s stock after purchasing an additional 11,979 shares during the period. Wealth Management Partners LLC’s holdings in ARK Genomic Revolution ETF were worth $1,481,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Baird Financial Group Inc. grew its holdings in shares of ARK Genomic Revolution ETF by 0.3% during the second quarter. Baird Financial Group Inc. now owns 73,722 shares of the company’s stock worth $3,101,000 after buying an additional 255 shares in the last quarter. Farther Finance Advisors LLC raised its position in shares of ARK Genomic Revolution ETF by 22.2% in the third quarter. Farther Finance Advisors LLC now owns 1,914 shares of the company’s stock valued at $104,000 after buying an additional 348 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of ARK Genomic Revolution ETF by 53.2% during the first quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock valued at $29,000 after buying an additional 378 shares during the period. Rockefeller Capital Management L.P. lifted its stake in shares of ARK Genomic Revolution ETF by 1.9% during the fourth quarter. Rockefeller Capital Management L.P. now owns 24,243 shares of the company’s stock valued at $702,000 after buying an additional 461 shares during the period. Finally, GK Wealth Management LLC purchased a new position in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $27,000.

ARK Genomic Revolution ETF Stock Performance

Shares of BATS ARKG opened at $49.85 on Thursday. ARK Genomic Revolution ETF has a 1 year low of $24.60 and a 1 year high of $58.83. The firm’s 50 day moving average price is $49.12 and its 200 day moving average price is $39.97.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.